Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1115 studies found for:    "Osteoporosis"
Show Display Options
RSS Create an RSS feed from your search for:
"Osteoporosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
Conditions: Osteoporosis;   Bone Loss, Age Related;   Postmenopausal Bone Loss;   Postmenopausal Osteoporosis
Intervention: Behavioral: Osteoporosis Choice Decision Aid
2 Completed
Has Results
A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab
Conditions: Low Bone Mass;   Low Bone Mineral Density;   Osteoporosis;   Postmenopausal Osteoporosis
Intervention: Drug: Previous denosumab
3 Active, not recruiting Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis, Steroid Induced
Intervention: Drug: Teriparatide
4 Completed Patient- and Physician-Based Osteoporosis Education
Conditions: Osteoporosis;   Osteoporosis, Postmenopausal
Intervention: Behavioral: Osteoporosis Education
5 Completed A Study for Teriparatide in Severe Osteoporosis
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis
Intervention: Drug: Teriparatide
6 Completed
Has Results
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
Conditions: Osteoporosis;   Postmenopausal Osteoporosis
Interventions: Drug: MK-5442;   Drug: Placebo to MK-5442;   Drug: Alendronate Sodium;   Drug: Vitamin D3;   Drug: Calcium carbonate;   Drug: Placebo to Alendronate
7 Completed PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
Conditions: Postmenopause;   Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH) (Preotact)
8 Unknown  Osteoporosis Coordinator for Low Volume Community Hospitals
Conditions: Osteoporosis;   Fragility Fractures
Interventions: Behavioral: centralized osteoporosis coordinator;   Behavioral: fall prevention
9 Completed Texture Analysis for Postmenopausal Osteoporosis
Conditions: Osteoporosis;   Osteopenia
Interventions: Drug: Alendronate;   Drug: Control
10 Completed Education for Osteoporosis in Persons With Existing Fractures
Condition: Osteoporosis
Interventions: Behavioral: Osteoporosis Prevention and Self-Management Course;   Behavioral: Introductory education session on osteoporosis
11 Unknown  Weekly vs Daily Teriparatide Therapy in Severe Postmenopausal Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
12 Completed Screening for Osteoporosis in General Practice
Condition: Osteoporosis
Intervention:
13 Completed Combination Osteogenic Therapy in Established Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: PTH 1-34;   Drug: MFPSR-fluoride
14 Not yet recruiting A Safety and Efficacy Study to Evaluate AMG 785 in South Korean Women With Osteoporosis.
Condition: Postmenopausal Osteoporosis (PMO)
Interventions: Drug: Romosozumab;   Drug: Placebo
15 Completed A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Denosumab (CP2);   Drug: Denosumab (CP4)
16 Completed
Has Results
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: Denosumab
17 Completed A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: ALX1-11 50 mcg;   Drug: placebo;   Drug: ALX1-11 75mcg;   Drug: ALX1-11
18 Completed Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Bazedoxifene Acetate (TSE-424)
19 Completed
Has Results
Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
Conditions: Osteopenia;   Osteoporosis
Intervention: Biological: Denosumab
20 Recruiting Preventing Osteoporosis Using Denosumab
Conditions: Osteoporosis, Postmenopausal;   Osteoporosis;   Osteoporotic Fractures
Interventions: Drug: denosumab;   Drug: Placebo;   Dietary Supplement: Calcium and Vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years